Table 1.
Biomedical model | Gene | Reference | Year |
---|---|---|---|
Gene expression | H2-Eα | [7] | 2004 |
Pharmacogenetic factors | |||
Warfarin | Cyp2c29 | [31] | 2006 |
Irinotecan | Ugt1a | [32] | 2007 |
P38 kinase inhibitor | Aox1 | [18] | 2010 |
Susceptibility to infection | |||
Invasive aspergillosis | Plg | [33] | 2008 |
Respiratory syncitial virus | MHC (H2) | [34] | 2010 |
Candida albicans | C1r/s | [14] | 2011 |
Analgesic medication response | Kcnj9 | [19] | 2008 |
Narcotic drug responses | |||
Mechanical hyperalgesia | Adrb2 | [35] | 2006 |
Thermal hyperalgesia | Abcb1b | [36] | 2006 |
Analgesia | Kcnj9 | [19] | 2008 |
Withdrawal | Ht3a | [4] | 2009 |
Inflammatory pain responses | |||
Early formalin response | Atp1b3 | [20] | 2009 |
Late formalin response | Mapk8 | [37] | 2010 |
Incisional wound biology | Nalp1b | [5], [6] | 2010 |